Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
Summit History
20th Bioshares Biotech Summit
Contact
Contact Us
Email Alerts
Categories
Categories
Actinogen (ACW)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Cynata Therapeutics
Dimerix (DXB)
Imugene (IMU)
Neuren Pharmaceuticals (NEU)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
February 20th, 2026
Actinogen Medical 'Increasingly Confident of Positive Outcome'
Read More
January 30th, 2026
Actinogen Medical Gets Green Light from Data Monitoring Committee
Read More
December 16th, 2025
Actinogen Medical - Good Rational for Positive Trial Outcome in 2026
Read More
August 26th, 2025
Actinogen Medical — Why Xanamem Should Deliver Positive Results in Phase IIb Alzheimer’s Disease Study
Read More
March 26th, 2025
Actinogen Medical: Progressing its Phase IIb/III Alzheimer's Study
Read More
Pages
1
